CVE-2014-5406: vulnerability in Hospira LifeCare PCA Infusion System
Hospira LifeCare PCA Infusion System
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
21Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 7.6epss 1.2%
The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.
AV:N/AC:H/Au:N/C:C/I:C/A:C
Affected products
Hospira · LifeCare PCA Infusion SystemRelated CVEs — Hospira LifeCare PCA Infusion System
In the same product, most dangerous first.
References
https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2015/icsa-15-125-01.jsonhttps://ics-cert.us-cert.gov/advisories/ICSA-15-125-01https://www.cisa.gov/news-events/ics-advisories/icsa-15-125-01https://xs-sniper.com/blog/2015/06/08/hospira-plum-a-infusion-pump-vulnerabilities/http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm446809.htm